Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts
Open Access
- 29 April 2003
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 88 (9), 1453-1461
- https://doi.org/10.1038/sj.bjc.6600907
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblastsInternational Journal of Gynecologic Cancer, 2001
- VEGF‐C and VEGF‐D expression in neuroendocrine cells and their receptor, VEGFR‐3, in fenestrated blood vessels in human tissuesThe FASEB Journal, 2000
- The Toxicology of Interleukin-12: A ReviewToxicologic Pathology, 1999
- Tumor Cell Responses to IFNγ Affect Tumorigenicity and Response to IL-12 Therapy and AntiangiogenesisImmunity, 1998
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Inhibition of Angiogenesis In Vivo by Interleukin 12JNCI Journal of the National Cancer Institute, 1995
- Antitumor and antimetastatic activity of interleukin 12 against murine tumors.The Journal of Experimental Medicine, 1993
- INDUCIBLE EXPRESSION OF AN ENDOTHELIAL CELL ANTIGEN ON MURINE MYOCARDIAL VASCULATURE IN ASSOCIATION WITH INTERSTITIAL CELLULAR INFILTRATIONTransplantation, 1989
- THE DETAILED DISTRIBUTION OF HLA-A, B, C ANTIGENS IN NORMAL HUMAN ORGANSTransplantation, 1984
- Hypoxia in neoplastic tissueMicrovascular Research, 1977